Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multicenter Phase II Trial of Temozolomide in Mycosis Fungoides/Sézary Syndrome: Correlation with O6-Methylguanine-DNA Methyltransferase and Mismatch Repair Proteins
Christiane Querfeld, Steven T. Rosen, Joan Guitart, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 17, pp. 5748-5754
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
Chunhai Fan, W-L Liu, Hua Cao, et al.
Cell Death and Disease (2013) Vol. 4, Iss. 10, pp. e876-e876
Open Access | Times Cited: 189
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
D. Gilson, Sean Whittaker, Fiona Child, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 496-526
Closed Access | Times Cited: 131
Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy
Man Kyu Shim, Yujeong Moon, Suah Yang, et al.
Biomaterials (2020) Vol. 261, pp. 120347-120347
Closed Access | Times Cited: 81
Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance
Jinseong Kim, Man Kyu Shim, Suah Yang, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 920-932
Closed Access | Times Cited: 54
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 99, pp. 214-227
Open Access | Times Cited: 47
Prodrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity
Ritika Kurian, Hongbing Wang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 988-988
Open Access
Cutaneous T Cell Lymphoma: Update of Treatment
H. S. Zackheim
Dermatology (1999) Vol. 199, Iss. 2, pp. 102-105
Closed Access | Times Cited: 90
Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
Guan Jiang, Ronghua Li, Chao Sun, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e111920-e111920
Open Access | Times Cited: 48
Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Lisa Argnani, Alessandro Broccoli, Pier Luigi Zinzani
Cancer Treatment Reviews (2017) Vol. 61, pp. 61-69
Closed Access | Times Cited: 34
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
Pier Luigi Zinzani, Vijayveer Bonthapally, Dirk Huebner, et al.
Critical Reviews in Oncology/Hematology (2016) Vol. 99, pp. 228-240
Open Access | Times Cited: 32
Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
Shruti Rao, Robert A. Beckman, Shahla Riazi, et al.
Oncotarget (2016) Vol. 8, Iss. 23, pp. 37923-37934
Open Access | Times Cited: 22
Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma
B. Moriarty, Sean Whittaker
Expert Review of Hematology (2014) Vol. 8, Iss. 2, pp. 159-171
Closed Access | Times Cited: 12
Temozolomide for central nervous system involvement in mycosis fungoides
Thomas G. Bird, Sean Whittaker, E. Mary Wain, et al.
International Journal of Dermatology (2015) Vol. 55, Iss. 7, pp. 751-756
Closed Access | Times Cited: 11
Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro
Catalina Silva‐Hirschberg, Hannah Hartman, Samantha Stack, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 11
The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review
Mehul Dalal, Stephen Mitchell, Conor McCloskey, et al.
Expert Review of Hematology (2020) Vol. 13, Iss. 4, pp. 405-419
Open Access | Times Cited: 11
Cutaneous Lymphomas: Molecular Pathways Leading to New Drugs
Reinhard Dummer, Simone M. Goldinger, Antonio Cozzio, et al.
Journal of Investigative Dermatology (2011) Vol. 132, Iss. 3, pp. 517-525
Open Access | Times Cited: 11
New drugs in cutaneous T-cell lymphomas
Julia Scarisbrick
Current Opinion in Oncology (2016) Vol. 28, Iss. 5, pp. 384-389
Closed Access | Times Cited: 9
Cutaneous T-Cell Lymphomas: A Review of New Discoveries and Treatments
Tara Bloom, Timothy M. Kuzel, Christiane Querfeld, et al.
Current Treatment Options in Oncology (2012) Vol. 13, Iss. 1, pp. 102-121
Closed Access | Times Cited: 9
Determination of Protein-Protein Interaction for Cancer Control via Mass Spectrometry and Nanoconductimetry of NAPPA SNAP Arrays: An Overview
Claudio Nicolini, Nicola Luigi Bragazzi, Eugenia Pechkova
NanoWorld Journal (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 8
Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review
Peggy A. Wu, Victor Huang, Michael Bigby
British Journal of Dermatology (2014) Vol. 170, Iss. 5, pp. 1015-1020
Closed Access | Times Cited: 7
Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
Ewa Chmielowska, Maciej Studziński, Sebastian Giebel, et al.
Advances in Dermatology and Allergology (2015) Vol. 2, pp. 67-72
Open Access | Times Cited: 6
Cutaneous T cell lymphoma: update on treatment
Uwe Wollina
International Journal of Dermatology (2012) Vol. 51, Iss. 9, pp. 1019-1036
Closed Access | Times Cited: 6
Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma
Catherine Chung, Brian Poligone
Dermatologic Clinics (2015) Vol. 33, Iss. 4, pp. 787-805
Open Access | Times Cited: 4
Drug-Protein Interactions for Clinical Research by Nucleic Acid Programmable Protein Arrays-Quartz Crystal Microbalance with Dissipation Factor Monitoring Nanoconductometric Assay
Claudio Nicolini, Rosanna Spera, Nicola Luigi Bragazzi, et al.
American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology (2014) Vol. 10, Iss. 3, pp. 189-201
Open Access | Times Cited: 4
Mycosis Fungoides
Grace L. Smith, Lynn D. Wilson, Bouthaina S. Dabaja
Elsevier eBooks (2015), pp. 1556-1576.e4
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top